The Oncofertility Consortium is happy to announce a new collaboration with the Cancer Knowledge Network. The Consortium was established to expand the reproductive future of cancer survivors whose disease or treatment may impair future fertility. This interdisciplinary, global cooperative of researchers, health care providers, and patients investigates barriers to fertility after cancer and overcomes these hurdles. It also facilitates information flow between stakeholders within the cancer community. Our partnership with the Cancer Knowledge Network will provide our readers cutting edge information on the advanced fertility preservation techniques available to cancer patients, oncofertility resources for the health care community, and new research in the field.
About the Oncofertility Consortium
Survival rates among young cancer patients have more than doubled over the past four decades, in part, because of the development of more effective cancer treatments. Today, women, men, and children can look forward to life after cancer, yet many may face the possibility of infertility as a result of the disease itself or these life-saving treatments. The Oncofertility Consortium addresses the complex fertility care and quality-of-life issues that concern young cancer patients.
The Consortium is an interprofessional network of medical specialists, scientists, and scholars who are exploring the relationships between health, disease, survivorship and fertility preservation in young cancer patients. Our work and its findings may also extend to patients who have been diagnosed with other serious diseases and who must undergo fertility-threatening treatments, such as stem-cell therapy.
The Oncofertility Consortium brings together professionals in reproductive medicine, reproductive health research, oncology, biomechanics, materials science, mathematics, social science, bioethics, religion, policy research and educational sciences to expand current knowledge, research, clinical practice, and training for a wide spectrum of issues including:
- The mechanisms underlying the fertility threat of life-preserving cancer drugs.
- Methods for cryopreservation (freezing), storing, and growing human ovarian and testicular tissue.
- Development of biomaterials to support in vitro growth of reproductive tissue.
- Communication barriers between cancer patients and providers.
- The influence of gender, age, race, ethnicity, socioeconomic and family status on cancer-related decision making.
- Ethical, religious, and legal concerns regarding the use of fertility preservation technologies in cancer patients.
- Cost, insurance, and benefit analyses of fertility preservation options.
Health care providers and the public can learn more about the Oncofertility Consortium through a variety of ways. Oncology specialists can read about the fertility options for cancer patients or download the free iSaveFertility iPhone App, fertility specialists can get involved with the National Physicians Cooperative, a network of fertility preservation specialists committed to providing care to cancer patients, and both can order oncofertility brochures for their patients. Patients, parents, and partners can learn more about cancer and fertility at SaveMyFertility.org, MyOncofertility.org, and by calling the fertility hotline, FERTLINE, at 866-708-FERT (3378).